Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
With nearly half of US pregnancies being unintended, fertility regulation methods that fit the population’s needs, especially women’s diverse needs, are crucial for improving sexual and reproductive health. NICHD is accepting applications to support and facilitate multidisciplinary research approaches for the development of novel nonsteroidal contraceptive products for women and men that act prior to fertilization, which could potentially include MPTs with contraceptive and infection prevention properties.

This FOA aims to position innovative and validated methods for future clinical development. Details and other relevant information can be found onwww.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: RFA-HD-19-015, then clicking on the opportunity number.

• Funding Opportunity #: RFA-HD-19-015
• Open Date: 6 October 2018
• Letter of Intent Due: 6 October 2018
• Application Due: 6 November 2018 by 5:00 p.m. local time of applicant organization